APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Glutamate Receptor Ionotropic NMDA 2B

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Glutamate Receptor Ionotropic NMDA 2B Market Analysis and Forecast 2026-2032

Report ID 173995730226 December 2025198 pages

Choose your research edition.

Industry ResearchGlutamate Receptor Ionotropic NMDA 2B Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Glutamate Receptor Ionotropic NMDA 2B Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Glutamate Receptor Ionotropic NMDA 2B Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glutamate Receptor Ionotropic NMDA 2B Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Glutamate Receptor Ionotropic NMDA 2B Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Glutamate Receptor Ionotropic NMDA 2B market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Glutamate Receptor Ionotropic NMDA 2B is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Glutamate Receptor Ionotropic NMDA 2B is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Glutamate Receptor Ionotropic NMDA 2B is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Glutamate Receptor Ionotropic NMDA 2B is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Glutamate Receptor Ionotropic NMDA 2B include Johnson & Johnson, Novartis AG, UCB S.A., NeurOp, Inc, Luc Therapeutics, Inc., Cerecor Inc., Bristol-Myers Squibb Company and BioCrea GmbH, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Glutamate Receptor Ionotropic NMDA 2B, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Glutamate Receptor Ionotropic NMDA 2B, also provides the sales of main regions and countries. Of the upcoming market potential for Glutamate Receptor Ionotropic NMDA 2B, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Glutamate Receptor Ionotropic NMDA 2B sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Glutamate Receptor Ionotropic NMDA 2B market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Glutamate Receptor Ionotropic NMDA 2B sales, projected growth trends, production technology, application and end-user industry.

Glutamate Receptor Ionotropic NMDA 2B Segment by Company

Johnson & Johnson

Novartis AG

UCB S.A.

NeurOp, Inc

Luc Therapeutics, Inc.

Cerecor Inc.

Bristol-Myers Squibb Company

BioCrea GmbH

Glutamate Receptor Ionotropic NMDA 2B Segment by Type

JNJ-0808

Radiprodil

NP-11948

NP-10679

Neu-2000

Others

Glutamate Receptor Ionotropic NMDA 2B Segment by Application

Burns

Acute Ischemic Stroke

Brain Ischemia

Autism

Others

Glutamate Receptor Ionotropic NMDA 2B Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glutamate Receptor Ionotropic NMDA 2B market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glutamate Receptor Ionotropic NMDA 2B and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glutamate Receptor Ionotropic NMDA 2B.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Glutamate Receptor Ionotropic NMDA 2B in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Glutamate Receptor Ionotropic NMDA 2B manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Glutamate Receptor Ionotropic NMDA 2B sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. JNJ-0808 Major Manufacturers Table 3. Radiprodil Major Manufacturers Table 4. NP-11948 Major Manufacturers Table 5. NP-10679 Major Manufacturers Table 6. Neu-2000 Major Manufacturers Table 7. Others Major Manufacturers Table 8. Global Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Burns Major Manufacturers Table 10. Acute Ischemic Stroke Major Manufacturers Table 11. Brain Ischemia Major Manufacturers Table 12. Autism Major Manufacturers Table 13. Others Major Manufacturers Table 14. Glutamate Receptor Ionotropic NMDA 2B Industry Trends Table 15. Glutamate Receptor Ionotropic NMDA 2B Industry Drivers Table 16. Glutamate Receptor Ionotropic NMDA 2B Industry Opportunities and Challenges Table 17. Glutamate Receptor Ionotropic NMDA 2B Industry Restraints Table 18. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2021-2026) & (US$ Million) Table 20. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2027-2032) & (US$ Million) Table 21. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Region (2021-2026) Table 22. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Region (2027-2032) Table 23. Global Glutamate Receptor Ionotropic NMDA 2B Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 24. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2021-2026) & (W Units) Table 25. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2027-2032) & (W Units) Table 26. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Region (2021-2026) Table 27. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Region (2027-2032) Table 28. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Manufacturers (2021-2026) Table 30. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Manufacturers (2021-2026) Table 32. Global Glutamate Receptor Ionotropic NMDA 2B Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 33. Global Glutamate Receptor Ionotropic NMDA 2B Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global Glutamate Receptor Ionotropic NMDA 2B Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global Glutamate Receptor Ionotropic NMDA 2B Manufacturers, Product Type & Application Table 36. Global Glutamate Receptor Ionotropic NMDA 2B Manufacturers' Establishment Date Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global Glutamate Receptor Ionotropic NMDA 2B by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2021-2026) & (US$ Million) Table 41. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2027-2032) & (US$ Million) Table 42. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type (2021-2026) Table 43. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type (2027-2032) Table 44. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 45. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021-2026) & (W Units) Table 46. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2027-2032) & (W Units) Table 47. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2021-2026) Table 48. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2027-2032) Table 49. Global Glutamate Receptor Ionotropic NMDA 2B Price by Type (2021-2026) & (US$/Unit) Table 50. Global Glutamate Receptor Ionotropic NMDA 2B Price by Type (2027-2032) & (US$/Unit) Table 51. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2021-2026) & (US$ Million) Table 53. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2027-2032) & (US$ Million) Table 54. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application (2021-2026) Table 55. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application (2027-2032) Table 56. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 57. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021-2026) & (W Units) Table 58. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2027-2032) & (W Units) Table 59. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2021-2026) Table 60. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2027-2032) Table 61. Global Glutamate Receptor Ionotropic NMDA 2B Price by Application (2021-2026) & (US$/Unit) Table 62. Global Glutamate Receptor Ionotropic NMDA 2B Price by Application (2027-2032) & (US$/Unit) Table 63. Johnson & Johnson Company Information Table 64. Johnson & Johnson Business Overview Table 65. Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 67. Johnson & Johnson Recent Development Table 68. Novartis AG Company Information Table 69. Novartis AG Business Overview Table 70. Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Novartis AG Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 72. Novartis AG Recent Development Table 73. UCB S.A. Company Information Table 74. UCB S.A. Business Overview Table 75. UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 77. UCB S.A. Recent Development Table 78. NeurOp, Inc Company Information Table 79. NeurOp, Inc Business Overview Table 80. NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 82. NeurOp, Inc Recent Development Table 83. Luc Therapeutics, Inc. Company Information Table 84. Luc Therapeutics, Inc. Business Overview Table 85. Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 87. Luc Therapeutics, Inc. Recent Development Table 88. Cerecor Inc. Company Information Table 89. Cerecor Inc. Business Overview Table 90. Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 92. Cerecor Inc. Recent Development Table 93. Bristol-Myers Squibb Company Company Information Table 94. Bristol-Myers Squibb Company Business Overview Table 95. Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 97. Bristol-Myers Squibb Company Recent Development Table 98. BioCrea GmbH Company Information Table 99. BioCrea GmbH Business Overview Table 100. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Product Portfolio Table 102. BioCrea GmbH Recent Development Table 103. North America Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2021-2026) & (US$ Million) Table 104. North America Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2027-2032) & (US$ Million) Table 105. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021-2026) & (W Units) Table 106. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2027-2032) & (W Units) Table 107. North America Glutamate Receptor Ionotropic NMDA 2B Sales Price by Type (2021-2026) & (US$/Unit) Table 108. North America Glutamate Receptor Ionotropic NMDA 2B Sales Price by Type (2027-2032) & (US$/Unit) Table 109. North America Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2021-2026) & (US$ Million) Table 110. North America Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2027-2032) & (US$ Million) Table 111. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021-2026) & (W Units) Table 112. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2027-2032) & (W Units) Table 113. North America Glutamate Receptor Ionotropic NMDA 2B Sales Price by Application (2021-2026) & (US$/Unit) Table 114. North America Glutamate Receptor Ionotropic NMDA 2B Sales Price by Application (2027-2032) & (US$/Unit) Table 115. North America Glutamate Receptor Ionotropic NMDA 2B Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Glutamate Receptor Ionotropic NMDA 2B Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 117. North America Glutamate Receptor Ionotropic NMDA 2B Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 118. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 119. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021-2026) & (W Units) Table 120. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2027-2032) & (W Units) Table 121. North America Glutamate Receptor Ionotropic NMDA 2B Sales Price by Country (2021-2026) & (US$/Unit) Table 122. North America Glutamate Receptor Ionotropic NMDA 2B Sales Price by Country (2027-2032) & (US$/Unit) Table 123. United States Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 124. Canada Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 125. Mexico Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 126. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2021-2026) & (US$ Million) Table 127. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2027-2032) & (US$ Million) Table 128. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021-2026) & (W Units) Table 129. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2027-2032) & (W Units) Table 130. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Price by Type (2021-2026) & (US$/Unit) Table 131. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Price by Type (2027-2032) & (US$/Unit) Table 132. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2021-2026) & (US$ Million) Table 133. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2027-2032) & (US$ Million) Table 134. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021-2026) & (W Units) Table 135. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2027-2032) & (W Units) Table 136. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Price by Application (2021-2026) & (US$/Unit) Table 137. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Price by Application (2027-2032) & (US$/Unit) Table 138. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 142. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021-2026) & (W Units) Table 143. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2027-2032) & (W Units) Table 144. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Price by Country (2021-2026) & (US$/Unit) Table 145. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Price by Country (2027-2032) & (US$/Unit) Table 146. Germany Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 147. France Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 148. U.K. Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 149. Italy Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 150. Russia Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 151. Spain Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 152. Netherlands Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 153. Switzerland Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 154. Sweden Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 155. Poland Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 156. China Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2021-2026) & (US$ Million) Table 157. China Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2027-2032) & (US$ Million) Table 158. China Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021-2026) & (W Units) Table 159. China Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2027-2032) & (W Units) Table 160. China Glutamate Receptor Ionotropic NMDA 2B Sales Price by Type (2021-2026) & (US$/Unit) Table 161. China Glutamate Receptor Ionotropic NMDA 2B Sales Price by Type (2027-2032) & (US$/Unit) Table 162. China Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2021-2026) & (US$ Million) Table 163. China Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2027-2032) & (US$ Million) Table 164. China Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021-2026) & (W Units) Table 165. China Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2027-2032) & (W Units) Table 166. China Glutamate Receptor Ionotropic NMDA 2B Sales Price by Application (2021-2026) & (US$/Unit) Table 167. China Glutamate Receptor Ionotropic NMDA 2B Sales Price by Application (2027-2032) & (US$/Unit) Table 168. Asia Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2021-2026) & (US$ Million) Table 169. Asia Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2027-2032) & (US$ Million) Table 170. Asia Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021-2026) & (W Units) Table 171. Asia Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2027-2032) & (W Units) Table 172. Asia Glutamate Receptor Ionotropic NMDA 2B Sales Price by Type (2021-2026) & (US$/Unit) Table 173. Asia Glutamate Receptor Ionotropic NMDA 2B Sales Price by Type (2027-2032) & (US$/Unit) Table 174. Asia Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2021-2026) & (US$ Million) Table 175. Asia Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2027-2032) & (US$ Million) Table 176. Asia Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021-2026) & (W Units) Table 177. Asia Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2027-2032) & (W Units) Table 178. Asia Glutamate Receptor Ionotropic NMDA 2B Sales Price by Application (2021-2026) & (US$/Unit) Table 179. Asia Glutamate Receptor Ionotropic NMDA 2B Sales Price by Application (2027-2032) & (US$/Unit) Table 180. Asia Glutamate Receptor Ionotropic NMDA 2B Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. Asia Glutamate Receptor Ionotropic NMDA 2B Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. Asia Glutamate Receptor Ionotropic NMDA 2B Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. Asia Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 184. Asia Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021-2026) & (W Units) Table 185. Asia Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2027-2032) & (W Units) Table 186. Asia Glutamate Receptor Ionotropic NMDA 2B Sales Price by Country (2021-2026) & (US$/Unit) Table 187. Asia Glutamate Receptor Ionotropic NMDA 2B Sales Price by Country (2027-2032) & (US$/Unit) Table 188. Japan Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 189. South Korea Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 190. India Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 191. Australia Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 192. Taiwan Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 193. Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 194. SAMEA Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2021-2026) & (US$ Million) Table 195. SAMEA Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2027-2032) & (US$ Million) Table 196. SAMEA Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021-2026) & (W Units) Table 197. SAMEA Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2027-2032) & (W Units) Table 198. SAMEA Glutamate Receptor Ionotropic NMDA 2B Sales Price by Type (2021-2026) & (US$/Unit) Table 199. SAMEA Glutamate Receptor Ionotropic NMDA 2B Sales Price by Type (2027-2032) & (US$/Unit) Table 200. SAMEA Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2021-2026) & (US$ Million) Table 201. SAMEA Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2027-2032) & (US$ Million) Table 202. SAMEA Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021-2026) & (W Units) Table 203. SAMEA Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2027-2032) & (W Units) Table 204. SAMEA Glutamate Receptor Ionotropic NMDA 2B Sales Price by Application (2021-2026) & (US$/Unit) Table 205. SAMEA Glutamate Receptor Ionotropic NMDA 2B Sales Price by Application (2027-2032) & (US$/Unit) Table 206. SAMEA Glutamate Receptor Ionotropic NMDA 2B Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. SAMEA Glutamate Receptor Ionotropic NMDA 2B Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. SAMEA Glutamate Receptor Ionotropic NMDA 2B Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. SAMEA Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 210. SAMEA Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021-2026) & (W Units) Table 211. SAMEA Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2027-2032) & (W Units) Table 212. SAMEA Glutamate Receptor Ionotropic NMDA 2B Sales Price by Country (2021-2026) & (US$/Unit) Table 213. SAMEA Glutamate Receptor Ionotropic NMDA 2B Sales Price by Country (2027-2032) & (US$/Unit) Table 214. Brazil Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 215. Argentina Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 216. Chile Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 217. Colombia Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 218. Peru Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 219. Saudi Arabia Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 220. Israel Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 221. UAE Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 222. Turkey Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 223. Iran Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 224. Egypt Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Table 225. Key Raw Materials Table 226. Raw Materials Key Suppliers Table 227. Glutamate Receptor Ionotropic NMDA 2B Distributors List Table 228. Glutamate Receptor Ionotropic NMDA 2B Customers List Table 229. Research Programs/Design for This Report Table 230. Authors List of This Report Table 231. Secondary Sources Table 232. Primary Sources List of Figures Figure 1. Glutamate Receptor Ionotropic NMDA 2B Image Figure 2. Global Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glutamate Receptor Ionotropic NMDA 2B Market Size Share 2021 VS 2025 VS 2032 Figure 4. JNJ-0808 Image Figure 5. Radiprodil Image Figure 6. NP-11948 Image Figure 7. NP-10679 Image Figure 8. Neu-2000 Image Figure 9. Others Image Figure 10. Global Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Glutamate Receptor Ionotropic NMDA 2B Market Size Share 2021 VS 2025 VS 2032 Figure 12. Burns Image Figure 13. Acute Ischemic Stroke Image Figure 14. Brain Ischemia Image Figure 15. Autism Image Figure 16. Others Image Figure 17. Global Glutamate Receptor Ionotropic NMDA 2B Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Glutamate Receptor Ionotropic NMDA 2B Revenue (2021-2032) & (US$ Million) Figure 19. Global Glutamate Receptor Ionotropic NMDA 2B Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Region: 2025 Versus 2032 Figure 21. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Region (2021-2032) Figure 22. Global Glutamate Receptor Ionotropic NMDA 2B Sales (2021-2032) & (W Units) Figure 23. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 24. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Region (2021-2032) Figure 25. US & Canada & Mexico Glutamate Receptor Ionotropic NMDA 2B Sales YoY (2021-2032) & (W Units) Figure 26. Europe Glutamate Receptor Ionotropic NMDA 2B Sales YoY (2021-2032) & (W Units) Figure 27. China Glutamate Receptor Ionotropic NMDA 2B Sales YoY (2021-2032) & (W Units) Figure 28. Asia (Excluding China) Glutamate Receptor Ionotropic NMDA 2B Sales YoY (2021-2032) & (W Units) Figure 29. South America, Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales YoY (2021-2032) & (W Units) Figure 30. Global Glutamate Receptor Ionotropic NMDA 2B Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 31. Global Glutamate Receptor Ionotropic NMDA 2B Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 32. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type (2021-2032) Figure 36. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 37. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 38. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2021-2032) Figure 39. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 40. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application (2021-2032) Figure 42. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 43. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 44. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2021-2032) Figure 45. North America Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Type (2021-2032) Figure 46. North America Glutamate Receptor Ionotropic NMDA 2B Sales Share by Type (2021-2032) Figure 47. North America Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Application (2021-2032) Figure 48. North America Glutamate Receptor Ionotropic NMDA 2B Sales Share by Application (2021-2032) Figure 49. North America Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Country (2021-2032) Figure 50. North America Glutamate Receptor Ionotropic NMDA 2B Sales Share by Country (2021-2032) Figure 51. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Type (2021-2032) Figure 52. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Share by Type (2021-2032) Figure 53. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Application (2021-2032) Figure 54. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Share by Application (2021-2032) Figure 55. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Country (2021-2032) Figure 56. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Share by Country (2021-2032) Figure 57. China Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Type (2021-2032) Figure 58. China Glutamate Receptor Ionotropic NMDA 2B Sales Share by Type (2021-2032) Figure 59. China Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Application (2021-2032) Figure 60. China Glutamate Receptor Ionotropic NMDA 2B Sales Share by Application (2021-2032) Figure 61. Asia Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Type (2021-2032) Figure 62. Asia Glutamate Receptor Ionotropic NMDA 2B Sales Share by Type (2021-2032) Figure 63. Asia Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Application (2021-2032) Figure 64. Asia Glutamate Receptor Ionotropic NMDA 2B Sales Share by Application (2021-2032) Figure 65. Asia Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Country (2021-2032) Figure 66. Asia Glutamate Receptor Ionotropic NMDA 2B Sales Share by Country (2021-2032) Figure 67. SAMEA Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Type (2021-2032) Figure 68. SAMEA Glutamate Receptor Ionotropic NMDA 2B Sales Share by Type (2021-2032) Figure 69. SAMEA Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Application (2021-2032) Figure 70. SAMEA Glutamate Receptor Ionotropic NMDA 2B Sales Share by Application (2021-2032) Figure 71. SAMEA Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Country (2021-2032) Figure 72. SAMEA Glutamate Receptor Ionotropic NMDA 2B Sales Share by Country (2021-2032) Figure 73. Glutamate Receptor Ionotropic NMDA 2B Value Chain Figure 74. Manufacturing Cost Structure Figure 75. Glutamate Receptor Ionotropic NMDA 2B Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Years Considered Figure 79. Research Process Figure 80. Key Executives Interviewed

Scope & coverage.

Types
  • JNJ-0808
  • Radiprodil
  • NP-11948
  • NP-10679
  • Neu-2000
  • Others
Applications
  • Burns
  • Acute Ischemic Stroke
  • Brain Ischemia
  • Autism
  • Others
Companies covered
  • Johnson & Johnson
  • Novartis AG
  • UCB S.A.
  • NeurOp, Inc
  • Luc Therapeutics, Inc.
  • Cerecor Inc.
  • Bristol-Myers Squibb Company
  • BioCrea GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Glutamate Receptor Ionotropic NMDA 2B Market by Type
  3. 1.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 JNJ-0808
  5. 1.2.3 Radiprodil
  6. 1.2.4 NP-11948
  7. 1.2.5 NP-10679
  8. 1.2.6 Neu-2000
  9. 1.2.7 Others
  10. 1.3 Glutamate Receptor Ionotropic NMDA 2B Market by Application
  11. 1.3.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Burns
  13. 1.3.3 Acute Ischemic Stroke
  14. 1.3.4 Brain Ischemia
  15. 1.3.5 Autism
  16. 1.3.6 Others
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Glutamate Receptor Ionotropic NMDA 2B Market Dynamics
  1. 2.1 Glutamate Receptor Ionotropic NMDA 2B Industry Trends
  2. 2.2 Glutamate Receptor Ionotropic NMDA 2B Industry Drivers
  3. 2.3 Glutamate Receptor Ionotropic NMDA 2B Industry Opportunities and Challenges
  4. 2.4 Glutamate Receptor Ionotropic NMDA 2B Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region
  3. 3.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2021-2026)
  5. 3.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2027-2032)
  6. 3.2.4 Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region
  9. 3.4.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2021-2026)
  11. 3.4.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2027-2032)
  12. 3.4.4 Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Manufacturers
  2. 4.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Glutamate Receptor Ionotropic NMDA 2B Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Manufacturers
  6. 4.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Glutamate Receptor Ionotropic NMDA 2B Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Glutamate Receptor Ionotropic NMDA 2B Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Glutamate Receptor Ionotropic NMDA 2B Manufacturers, Product Type & Application
  13. 4.7 Global Glutamate Receptor Ionotropic NMDA 2B Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Glutamate Receptor Ionotropic NMDA 2B Market CR5 and HHI
  16. 4.8.2 2025 Glutamate Receptor Ionotropic NMDA 2B Tier 1, Tier 2, and Tier 3
5 Glutamate Receptor Ionotropic NMDA 2B Market by Type
  1. 5.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type
  2. 5.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type
  6. 5.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2021-2032)
  9. 5.3 Global Glutamate Receptor Ionotropic NMDA 2B Price by Type
6 Glutamate Receptor Ionotropic NMDA 2B Market by Application
  1. 6.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application
  2. 6.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application
  6. 6.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2021-2032)
  9. 6.3 Global Glutamate Receptor Ionotropic NMDA 2B Price by Application
7 Company Profiles
  1. 7.1 Johnson & Johnson
  2. 7.1.1 Johnson & Johnson Company Information
  3. 7.1.2 Johnson & Johnson Business Overview
  4. 7.1.3 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  6. 7.1.5 Johnson & Johnson Recent Developments
  7. 7.2 Novartis AG
  8. 7.2.1 Novartis AG Company Information
  9. 7.2.2 Novartis AG Business Overview
  10. 7.2.3 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  12. 7.2.5 Novartis AG Recent Developments
  13. 7.3 UCB S.A.
  14. 7.3.1 UCB S.A. Company Information
  15. 7.3.2 UCB S.A. Business Overview
  16. 7.3.3 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  18. 7.3.5 UCB S.A. Recent Developments
  19. 7.4 NeurOp, Inc
  20. 7.4.1 NeurOp, Inc Company Information
  21. 7.4.2 NeurOp, Inc Business Overview
  22. 7.4.3 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  24. 7.4.5 NeurOp, Inc Recent Developments
  25. 7.5 Luc Therapeutics, Inc.
  26. 7.5.1 Luc Therapeutics, Inc. Company Information
  27. 7.5.2 Luc Therapeutics, Inc. Business Overview
  28. 7.5.3 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  30. 7.5.5 Luc Therapeutics, Inc. Recent Developments
  31. 7.6 Cerecor Inc.
  32. 7.6.1 Cerecor Inc. Company Information
  33. 7.6.2 Cerecor Inc. Business Overview
  34. 7.6.3 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  36. 7.6.5 Cerecor Inc. Recent Developments
  37. 7.7 Bristol-Myers Squibb Company
  38. 7.7.1 Bristol-Myers Squibb Company Company Information
  39. 7.7.2 Bristol-Myers Squibb Company Business Overview
  40. 7.7.3 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  42. 7.7.5 Bristol-Myers Squibb Company Recent Developments
  43. 7.8 BioCrea GmbH
  44. 7.8.1 BioCrea GmbH Company Information
  45. 7.8.2 BioCrea GmbH Business Overview
  46. 7.8.3 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
  48. 7.8.5 BioCrea GmbH Recent Developments
8 North America
  1. 8.1 North America Glutamate Receptor Ionotropic NMDA 2B Market Size by Type
  2. 8.1.1 North America Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2021-2032)
  3. 8.1.2 North America Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021-2032)
  4. 8.1.3 North America Glutamate Receptor Ionotropic NMDA 2B Price by Type (2021-2032)
  5. 8.2 North America Glutamate Receptor Ionotropic NMDA 2B Market Size by Application
  6. 8.2.1 North America Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2021-2032)
  7. 8.2.2 North America Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021-2032)
  8. 8.2.3 North America Glutamate Receptor Ionotropic NMDA 2B Price by Application (2021-2032)
  9. 8.3 North America Glutamate Receptor Ionotropic NMDA 2B Market Size by Country
  10. 8.3.1 North America Glutamate Receptor Ionotropic NMDA 2B Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Glutamate Receptor Ionotropic NMDA 2B Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Glutamate Receptor Ionotropic NMDA 2B Market Size by Type
  2. 9.1.1 Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2021-2032)
  3. 9.1.2 Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021-2032)
  4. 9.1.3 Europe Glutamate Receptor Ionotropic NMDA 2B Price by Type (2021-2032)
  5. 9.2 Europe Glutamate Receptor Ionotropic NMDA 2B Market Size by Application
  6. 9.2.1 Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2021-2032)
  7. 9.2.2 Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021-2032)
  8. 9.2.3 Europe Glutamate Receptor Ionotropic NMDA 2B Price by Application (2021-2032)
  9. 9.3 Europe Glutamate Receptor Ionotropic NMDA 2B Market Size by Country
  10. 9.3.1 Europe Glutamate Receptor Ionotropic NMDA 2B Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Glutamate Receptor Ionotropic NMDA 2B Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Glutamate Receptor Ionotropic NMDA 2B Market Size by Type
  2. 10.1.1 China Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2021-2032)
  3. 10.1.2 China Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021-2032)
  4. 10.1.3 China Glutamate Receptor Ionotropic NMDA 2B Price by Type (2021-2032)
  5. 10.2 China Glutamate Receptor Ionotropic NMDA 2B Market Size by Application
  6. 10.2.1 China Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2021-2032)
  7. 10.2.2 China Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021-2032)
  8. 10.2.3 China Glutamate Receptor Ionotropic NMDA 2B Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Glutamate Receptor Ionotropic NMDA 2B Market Size by Type
  2. 11.1.1 Asia Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2021-2032)
  3. 11.1.2 Asia Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021-2032)
  4. 11.1.3 Asia Glutamate Receptor Ionotropic NMDA 2B Price by Type (2021-2032)
  5. 11.2 Asia Glutamate Receptor Ionotropic NMDA 2B Market Size by Application
  6. 11.2.1 Asia Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2021-2032)
  7. 11.2.2 Asia Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021-2032)
  8. 11.2.3 Asia Glutamate Receptor Ionotropic NMDA 2B Price by Application (2021-2032)
  9. 11.3 Asia Glutamate Receptor Ionotropic NMDA 2B Market Size by Country
  10. 11.3.1 Asia Glutamate Receptor Ionotropic NMDA 2B Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Glutamate Receptor Ionotropic NMDA 2B Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Glutamate Receptor Ionotropic NMDA 2B Market Size by Type
  2. 12.1.1 SAMEA Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Glutamate Receptor Ionotropic NMDA 2B Price by Type (2021-2032)
  5. 12.2 SAMEA Glutamate Receptor Ionotropic NMDA 2B Market Size by Application
  6. 12.2.1 SAMEA Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Glutamate Receptor Ionotropic NMDA 2B Price by Application (2021-2032)
  9. 12.3 SAMEA Glutamate Receptor Ionotropic NMDA 2B Market Size by Country
  10. 12.3.1 SAMEA Glutamate Receptor Ionotropic NMDA 2B Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Glutamate Receptor Ionotropic NMDA 2B Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Glutamate Receptor Ionotropic NMDA 2B Value Chain Analysis
  2. 13.1.1 Glutamate Receptor Ionotropic NMDA 2B Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Glutamate Receptor Ionotropic NMDA 2B Production Mode & Process
  6. 13.2 Glutamate Receptor Ionotropic NMDA 2B Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Glutamate Receptor Ionotropic NMDA 2B Distributors
  9. 13.2.3 Glutamate Receptor Ionotropic NMDA 2B Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst